IFN-α pretreatment of hMxA-tg mice reduced viral titres ∼3-fold in the upper respiratory tract, ∼44-fold in the trachea and ∼33-fold in the lung compared to IFN-α stimulated B6 control mice at 1 day post infection. This evidence concerns the gene TG and infection.